Tuesday, January 24, 2017

BRIEF-Celgene Inc says Health Canada has expanded indication for REVLIMID in multiple myeloma

* Celgene Inc says Health Canada has expanded indication for

REVLIMID in multiple myeloma

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)